Status:
UNKNOWN
Treatment of Severe Acute Respiratory Distress Syndrome With Allogeneic Bone Marrow-derived Mesenchymal Stromal Cells
Lead Sponsor:
Karolinska University Hospital
Collaborating Sponsors:
Karolinska Institutet
Conditions:
Acute Respiratory Distress Syndrome, Adult
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This is a multi-center, open-label, non-randomized controlled trial. Patients with viral-induced acute respiratory distress syndrome (ARDS) on extracorporeal membrane oxygenation (ECMO) will be eligib...
Eligibility Criteria
Inclusion
- ≥ 18 years of age
- Viral-induced acute respiratory distress syndrome
- Ventilator treatment
- Extracorporeal membrane oxygenation treatment
- Relatives provide written informed consent
Exclusion
- None
Key Trial Info
Start Date :
March 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT02215811
Start Date
March 1 2014
Last Update
August 13 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital
Stockholm, Sweden
2
Uppsala University Hospital
Uppsala, Sweden